TABLE 2.
Study population | |
LVEDV, ml | 93 (74.5; 108) |
LVESV, ml | 39 (30; 51) |
LVEF, % | 55 (49.5; 61.5) |
LVEDD, mm | 48 (45; 52.3) |
LVDSD, mm | 35 (30; 39) |
Septum, mm | 9.5 (9; 11) |
Posterior wall, mm | 9 (8; 10) |
Left atrial volume, ml/m2 | 46 (40; 55) |
E/A | 0.9 (0.7; 1.3) |
E/e′ | 9.4 (7.6; 12.9) |
TAPSE, mm | 24.5 (22; 27.3) |
SPAP, mmHg | 27.5 (25; 30) |
MR grade 0; 1; 2; ≥3 n (%) | 10 (15.2); 42(63.6); 14 (21.2); 0 (0) |
AR grade 0; 1; 2; ≥3 n (%) | 27 (40.9); 37 (56.1); 2 (3); 0 (0) |
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; TAPSE, tricuspid annular plane systolic excursion; SPAP, systolic pulmonary artery pressure; MR, mitral regurgitation; AR, aortic regurgitation.